NVST
Strong BuyFull HouseAPPROVEEnvista Holdings Corporation · Healthcare · United States · $4.4B · Avg Vol: $62M/d
Full House: Strong business, sensible price, market agrees. The rare full house.
Envista Holdings clears the calibrated bar. All three legs are above the floor (Q57 V51 M78) and an active buyback provides the required corroboration. Nothing adverse is on file: no negative earnings revision and no insider selling. Strong momentum at M78 suggests the market is beginning to confirm the dental recovery.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT ENVISTA HOLDINGS CORPORATION
Read
Envista Holdings Corporation manufactures and distributes dental products, including consumables, equipment, and digital imaging solutions, serving dental professionals worldwide. It leverages a broad portfolio of well-known dental brands and a global sales and distribution network to maintain its competitive standing. Spun off from Danaher Corporation, Envista is a significant player in the dental industry with a focus on innovation and digital dentistry.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 2.6B | 2.6B | 2.5B | 2.7B | 1.9% | 2.9B | 2.9B | 3.0B | 4.7% |
| EPS | 2.11 | 1.49 | -0.60 | -6.50 | 0.28 | -39.6% | 0.58 | 0.36 | 0.39 | 18.3% |
| Shares | — | 163.2M | 171.5M | 172.2M | 163.8M | +0.4% | 160.6M | — | — | — |
| Debt | — | 1.5B | 1.7B | 1.5B | 1.6B | 1.5% | 1.6B | — | — | — |
| Equity | — | 4.2B | 4.2B | 2.9B | 3.1B | -9.6% | — | — | — | — |
| Op CF | — | 182.7M | 275.7M | 336.5M | 275.7M | 14.7% | 302.6M | — | — | — |
| Inv CF | — | -657.3M | -62.4M | -54.6M | -51.1M | — | — | — | — | — |
| Fin CF | — | 12.5M | 118.9M | -103.7M | -170.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NVST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NVST | Envista Holdings Corporation(you) | $4.4B | 85 | Strong Buy |
| MMSI | Merit Medical Systems, Inc. | $5.4B | 82 | Strong Buy |
| ALGN | Align Technology, Inc. | $11.2B | 85 | Strong Buy |
| ICUI | ICU Medical, Inc. | $4.4B | 63 | Hold |
| ATR | AptarGroup, Inc. | $8.5B | 74 | Buy |
| TFX | Teleflex Incorporated | $5.9B | 66 | Buy |
| SOLV | Solventum Corporation | $15.5B | 83 | Strong Buy |
| AVTR | Avantor, Inc. | $9.9B | 70 | Buy |
| ATRC | AtriCure, Inc. | $2.5B | 64 | Hold |
| BAX | Baxter International Inc. | $13.5B | 73 | Buy |
Peer medians: ROE -31.0% · P/E 25.0x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.